Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Edoxaban in NVAF Patients with Acute Heart Failure
jRCTs031190006Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of edoxaban in Atrial fibrillation (AFib) and Acute Heart Failure (AHF), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Ratio of early trough edoxaban concentration to final trough concentration and Transition of trough edoxaban plasma concentration over time. Started May 2019; status: completed.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)Acute Heart Failure (AHF)
Beyond the preview
Go deeper on jRCTs031190006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190006.